rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-10-15
|
pubmed:abstractText |
To define the activity and toxicity of preoperative chemotherapy and postoperative concomitant chemoradiotherapy in patients with carcinoma of the esophagus, and to determine the effect on survival in patients treated with this approach.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
647-51
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:9681079-Adult,
pubmed-meshheading:9681079-Aged,
pubmed-meshheading:9681079-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9681079-Carcinoma,
pubmed-meshheading:9681079-Cisplatin,
pubmed-meshheading:9681079-Combined Modality Therapy,
pubmed-meshheading:9681079-Esophageal Neoplasms,
pubmed-meshheading:9681079-Esophagus,
pubmed-meshheading:9681079-Female,
pubmed-meshheading:9681079-Fluorouracil,
pubmed-meshheading:9681079-Follow-Up Studies,
pubmed-meshheading:9681079-Humans,
pubmed-meshheading:9681079-Leucovorin,
pubmed-meshheading:9681079-Male,
pubmed-meshheading:9681079-Middle Aged,
pubmed-meshheading:9681079-Radiotherapy Dosage,
pubmed-meshheading:9681079-Remission Induction,
pubmed-meshheading:9681079-Survival Rate,
pubmed-meshheading:9681079-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis.
|
pubmed:affiliation |
Department of Medicine, University of Chicago, IL, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|